October 01, 2014 1:41 PM ET

Commercial Services and Supplies

Company Overview of Canada’s Research-Based Pharmaceutical Companies

Executive Profile

Dawn Graham

Interim Chief Commercial Officer and Director, Medivation, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
61$1,350,391

Background

Mrs. Dawn Graham, also known as Svoronos, has been an Interim Chief Commercial Officer of Medivation, Inc. since July 10, 2014. Ms. Graham served as the President of Merck Canada Inc. (Merck Frosst Canada Ltd). since September 2006. Until March 2011, Ms. Graham served at from Merck & Co. Inc. Ms. Graham has over 25 years of extensive and varied experience in the pharmaceutical industry. Ms. Graham has more than 30 years of experience in the pharmaceutical industry in ...

Corporate Headquarters

55 Metcalfe Street
Ottawa, Ontario K1P 6L5

Canada

Phone: 613-236-0455
Fax: 613-236-6756

Board Members Memberships

Chairman
Chair
2013-Present
Chairman of the Board, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2013-Present
Interim Chief Commercial Officer and Director

Education

BA
Carleton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$93,750
Total Calculated Compensation$1,350,391
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Daniel G. Welch Chief Executive Officer and President
InterMune, Inc.
$703.4K
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia - Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
$8.6M
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
$17.6M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Canada’s Research-Based Pharmaceutical Companies, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.